As of April 15, 2025, Shionogi (4507.T) has a market cap of $13.68 billion USD. According to our data, Shionogi is ranked No.1251 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $13.68 B |
3.67%
|
Dec 30, 2024 | $13.20 B |
3.06%
|
Dec 29, 2023 | $12.81 B |
5.70%
|
Dec 30, 2022 | $12.12 B |
-17.57%
|
Dec 30, 2021 | $14.70 B |
51.53%
|
Dec 30, 2020 | $9.70 B |
-13.54%
|
Dec 30, 2019 | $11.22 B |
11.29%
|
Dec 31, 2018 | $10.08 B |
5.62%
|
Dec 29, 2017 | $9.55 B |
10.30%
|
Dec 30, 2016 | $8.66 B |
3.04%
|
Dec 30, 2015 | $8.40 B |
80.62%
|
Dec 30, 2014 | $4.65 B |
46.62%
|
Dec 30, 2013 | $3.17 B |
62.17%
|
Dec 28, 2012 | $1.96 B |
55.68%
|
Dec 30, 2011 | $1.26 B |
-33.97%
|
Dec 30, 2010 | $1.90 B |
-14.63%
|
Dec 30, 2009 | $2.23 B |
-9.38%
|
Dec 30, 2008 | $2.46 B |
17.69%
|
Dec 28, 2007 | $2.09 B |
-13.81%
|
Dec 29, 2006 | $2.42 B |
43.29%
|
Dec 30, 2005 | $1.69 B |
19.52%
|
Dec 31, 2004 | $1.42 B |
-28.66%
|
Dec 31, 2003 | $1.98 B |
19.50%
|
Dec 31, 2002 | $1.66 B |
-23.85%
|
Dec 31, 2001 | $2.18 B |
-3.06%
|
Dec 29, 2000 | $2.25 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
Market Cap | = | 4507.T Stock Price | * | 4507.T Shares Outstanding |
= | $16.09 | * | 0.85 B | |
= | $13.68 B |